Thrasos: Thrasos Innovation raises $21 mln
Thrasos Innovation has raised a $21 million financing round from investors including the Fonds de solidarité FTQ, BDC Venture Capital and SR One. Thrasos, of Montreal, is biotech focused on developing therapies to treat kidney disease.
Read full article »
CEO
Thrasos is a therapeutics company, engages in the discovery and development of targeted therapies for the prevention and treatment of Renal disease.
Read more